首页|Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial

Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial

扫码查看

Peripheral T-cell lymphomaChidamidePrednisoneCyclophosphamideThalidomideAll-oral regimen

Liang Jinhua、Wang Li、Wang Xiaodong、Cui Guohui、Zhou Jianfeng、Xing Tongyao、Du Kaixin、Xu Jingyan、Wang Luqun、Liang Rong、Chen Biyun、Cheng Jian、Shen Haorui、Li Jianyong、Xu Wei、Gao Ting、Hao Xiuyuan

展开 >

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China

Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu 210029, China

Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu 210029, China

Department of Hematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, China

Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

Department of Hematology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China

Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250000, China

Department of Hematology, Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi 710032, China

Department of Hematology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China

Department of Hematology, Zhongda Hospital, Medical School of Southeast University, Nanjing, Jiangsu 210009, China

展开 >

Peripheral T-cell lymphoma Chidamide Prednisone Cyclophosphamide Thalidomide All-oral regimen

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(13)